1. Home
  2. BGLC vs DSS Comparison

BGLC vs DSS Comparison

Compare BGLC & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

N/A

Current Price

$2.30

Market Cap

4.9M

Sector

Health Care

ML Signal

N/A

DSS

DSS Inc.

HOLD

Current Price

$0.49

Market Cap

5.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGLC
DSS
Founded
2017
1984
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Medical Specialities
Containers/Packaging
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
5.3M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
BGLC
DSS
Price
$2.30
$0.49
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.0K
36.5K
Earning Date
04-14-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
45.78
42.45
EPS
N/A
N/A
Revenue
$7,424,911.00
$2,085,000.00
Revenue This Year
N/A
$1.21
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.92
$0.47
52 Week High
$15.19
$1.90

Technical Indicators

Market Signals
Indicator
BGLC
DSS
Relative Strength Index (RSI) 55.51 41.31
Support Level $2.14 N/A
Resistance Level $2.73 $1.04
Average True Range (ATR) 0.13 0.04
MACD 0.03 0.01
Stochastic Oscillator 60.57 61.06

Price Performance

Historical Comparison
BGLC
DSS

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

About DSS DSS Inc.

DSS Inc is operating a business focused on four operating segments: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. Currently operates five distinct business lines that operate around the globe with primary operations in North America and Asia. Product packaging manufactures and sells sophisticated custom folding cartons, mailers, photo sleeves, and complex three-dimensional direct mail solutions. The biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the Securities and Investment Management.

Share on Social Networks: